Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • AIDS

    Tag: aids

    You Searched For "AIDS"
    Abbott discovers new strain of HIV, keeping global health community step ahead of virus

    Abbott discovers new strain of HIV, keeping global health community step ahead of virus

    Medical Dialogues Bureau10 Nov 2019 9:00 AM IST
    New Delhi: Abbott announced recently that a team of its scientists identified a new subtype of the human immunodeficiency virus (HIV), called HIV-1...
    Landmark: Sanofi announces to reduce price of TB drug Rifapentine by 70 percent

    Landmark: Sanofi announces to reduce price of TB drug Rifapentine by 70 percent

    Medical Dialogues Bureau1 Nov 2019 3:29 PM IST
    Scale-up of affordable Rifapentine stands to benefit over a million people in India alone, where more people suffer from TB than anywhere else in the...
    JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030

    JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030

    Medical Dialogues Bureau7 Oct 2019 9:30 AM IST
    NEW BRUNSWICK: Johnson & Johnson (JnJ) recently announced it has committed to ensuring more than $500 million is dedicated to world-class research...
    Sub-committee to align Drugs And Cosmetics, Magical Remedies Act to regulate Medical Advertisements: CDSCO Committee

    Sub-committee to align Drugs And Cosmetics, Magical Remedies Act to regulate Medical Advertisements: CDSCO Committee

    Farhat Nasim2 Oct 2019 11:48 AM IST
    New Delhi: The Drug Consultative Committee (DCC), functional under the apex drug regulatory body, Central Drug Standard Control Organisation (CDSCO)...
    Laurus Labs gets USFDA Establishment Inspection Report for Visakhapatnam units

    Laurus Labs gets USFDA Establishment Inspection Report for Visakhapatnam units

    Medical Dialogues Bureau6 Sept 2019 1:03 PM IST
    The establishment inspection report (EIR) from US Food and Drug Administration (USFDA) is for company's active pharmaceutical ingredients units 1 and...
    Strides Pharma found destroying, dumping drug production documents: USFDA Investigation

    Strides Pharma found destroying, dumping drug production documents: USFDA Investigation

    Medical Dialogues Bureau20 July 2019 2:16 PM IST
    In the letter to Strides Pharma, the FDA didn't explain whether its inspectors often check scrap yards or shredding rooms for documents, or whether it...
    Gilead Sciences chooses Chengdu Hi-tech Zone for Western China Operation Center project

    Gilead Sciences chooses Chengdu Hi-tech Zone for Western China Operation Center project

    Medical Dialogues Bureau12 July 2019 9:10 AM IST
    Established in 1987 and headquartered in California, Gilead Sciences is one of the top 10 pharmaceutical companies in the world. As a pioneer in...
    CDSCO releases Risk classification of newly notified Medical Devices, IVDs; Details

    CDSCO releases Risk classification of newly notified Medical Devices, IVDs; Details

    Meghna A Singhania18 May 2019 2:08 PM IST
    New Delhi: Through a recent notification, country's central medical device regulator, the Central Drugs Standards Control Organization (CDSCO) has...
    GSK gets USFDA nod for HIV-1 drug branded as Dovato

    GSK gets USFDA nod for HIV-1 drug branded as Dovato

    Farhat Nasim9 April 2019 9:20 AM IST
    GSK already has two-drug regimen Juluca on the market, but only for the smaller market of HIV patients that have received prior treatment. Dovato is...
    Laurus Labs gets tentative USFDA approval for HIV combo drug

    Laurus Labs gets tentative USFDA approval for HIV combo drug

    Farhat Nasim4 Feb 2019 9:30 AM IST
    Hyderabad: Indian pharmaceutical player, Laurus Labs said Sunday it has received tentative approval from the United States Food and Drug...
    Cipla gets WHO approval to sell TB preventing drug in HIV patients

    Cipla gets WHO approval to sell TB preventing drug in HIV patients

    Ruby Khatun Khatun1 Dec 2017 2:40 PM IST
    New Delhi: Drug major Cipla said it has received approval from the World Health Organisation (WHO) for Q-TIB, a combination drug indicated to help...
    FDA approves first two-drug HIV regimen from GSK

    FDA approves first two-drug HIV regimen from GSK

    Ruby Khatun Khatun24 Nov 2017 10:37 AM IST
    NEW YORK: The U.S. Food and Drug Administration (FDA) on Tuesday approved the first two-drug regimen to treat HIV, the virus that causes AIDS, aimed...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok